These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Study of the stabilization of zinc phthalocyanine in sol-gel TiO2 for photodynamic therapy applications.
    Author: Lopez T, Ortiz E, Alvarez M, Navarrete J, Odriozola JA, Martinez-Ortega F, Páez-Mozo EA, Escobar P, Espinoza KA, Rivero IA.
    Journal: Nanomedicine; 2010 Dec; 6(6):777-85. PubMed ID: 20493967.
    Abstract:
    Photodynamic therapy (PDT) has emerged as an alternative and promising noninvasive treatment for cancer. It is a two-step procedure that uses a combination of molecular oxygen, visible light, and photosensitizer (PS) agents; phthalocyanine (Pc) was supported over titanium oxide but has not yet been used for cell inactivation. Zinc phthalocyanine (ZnPc) molecules were incorporated into the porous network of titanium dioxide (TiO(2)) using the sol-gel method. It was prepared from stock solutions of ZnPc and TiO(2). ZnPc-TiO(2) was tested with four cancer cell lines. The characterization of supported ZnPc showed that phthalocyanine is linked by the N-pyrrole to the support and is stable up to 250°C, leading to testing for PDT. The preferential localization in target organelles such as mitochondria or lysosomes could determine the cell death mechanism after PDT. The results suggest that nanoparticulated TiO(2) sensitized with ZnPc is an excellent candidate as sensitizer in PDT against cancer and infectious diseases.
    [Abstract] [Full Text] [Related] [New Search]